As of 4:01pm ET
| +0.76 / +1.46%|
The 20 analysts offering 12-month price forecasts for Imperva Inc have a median target of 50.00, with a high estimate of 64.00 and a low estimate of 33.00. The median estimate represents a -5.32% decrease from the last price of 52.81.
The current consensus among 22 polled investment analysts is to Buy stock in Imperva Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.